An asthma attack is usually mediated by an inflammatory pathway, where a trigger such as an allergen could lead to a series of immune response mediated by various types of immune cells.[3]
Common triggers for asthma include allergens like pet dander, dust mites, pollens and molds. Other types of triggers like exercise, air pollutants, tobacco smoke, humidity, cold air, or certain medicines may also play a role in triggering asthma.[4] While it has been proposed that asthma triggers can be classified into three types: allergic triggers, environmental triggers and physical triggers, a universal categorization of asthma triggers has yet to be done.[4] Other studies have also classified asthma triggers into psychological factors, air pollutants, physical activity, allergens and infection.[5]
Asthma is an extremely common chronic disease affecting over 26 million people and 7 million children in the US.[3] Recognizing the trigger for asthma and avoiding it can be a simple yet effective way to deal with the disease and avoid an asthma attack.[6] Although a cure for asthma is yet to be invented, various treatment methods are available for both long-term control and immediate relieve of an asthma attack.[7]
Pathophysiologyedit
The pathophysiology for asthma mainly involves the inflammatory pathway, associated with several types of immune cells in the body, mainly T helper 2 cells (Th2 cells), B cells and mast cells. In a nut shell, as a stimulus, such as an allergen comes into contact with an asthma patient, it activates various types of immune cells leading to an inflammatory response, causing bronchial hyperresponsiveness, bronchoconstriction, excessive mucus secretion, airflow obstruction and an asthma attack.[3] A more detail rundown of the process is provided below.
Allergens are the most common trigger for allergic asthma. Examples of such triggers of asthma include naturally occurring aeroallergens like house dust mites, animal feces and pollen.[21]Pets, molds and pests are also potential triggers.[22] When an asthma patient inhales or come into contact withsuch allergen, mast cells in the airway tract releases vasoactive amines and proteases. This leads to a release of cytokines and mediates a broad range of inflammatory and allergic responses.[19]
Environmental triggersedit
In addition to allergens, studies have revealed that environmental factors may also increase the risk of triggering an asthma attack.[21][23] Examples of these factors include respiratory tract viral infections,[24] exposure to air pollutants such as ozone[25] or a change in lifestyle that involves a decrease in exposure to microbes and their products like endotoxin.[26] Although its mechanism of action is still unknown, an in vivo study[21] has demonstrated that these environmental factors lead to the accumulation of neutrophil extracellular traps (NET) releasing neutrophils in the lungs. This increased release of NETs have been found to be associated with asthmatic symptoms such as mucus hypersecretion.[27]
Another environmental risk factor is exposure to formaldehyde.[28] Formaldehyde itself is a chemical that can cause irritation to the respiratory tract. In addition, it may react with macromolecules such as albumin which can induce the production of igE antibodies which can bind to mast cells and lead to hyperresponsiveness of the respiratory tract.[28]
Exerciseedit
Exercise induced asthma is common in most asthma patients.[29] Although the mechanism for such a phenomenon is still unclear, researchers have proposed that as the body gasps for more oxygen during exercise, more cold and dry air is inhaled. The passage of this cold and dry air causes a loss of moisture from the mucosal membrane of the respiratory tract. The osmolarity changes brought by such action can lead to an increased release of proinflammatory mediators such as cytokines, leading to a hypersensitivity of the airway.[30][31] Cooling of the respiratory tract may also activate cholinergic receptors, which can induce bronchoconstriction and mucus secretion, further narrowing the airway.[32] Swimmers with asthma may also inhale an excess amount of contaminated and irritating air with compound derived from chlorine gas, this can increase the risk of an asthma attack.[33]
After the inhibition of cyclooxygenase-1 enzyme by the NSAIDs, an accumulation of arachidonic acid will be resulted. This, in turn, would increase the production of leukotrienes. Leukotrienes is an inflammatory mediator. The accumulation of proinflammatory leukotrienes would overstimulate the cysteinyl leukotriene receptors in the respiratory system, leading to bronchoconstriction and the over-secretion of mucus, thus blocking the airway.[34]
Beta-blocker, or beta-adrenergic antagonists, may also induce bronchial constriction and block the action of other beta-receptor targeted asthmatic drugs, leading to a worsening asthma condition.[35] Therefore, asthma patients should be cautious and inform their physicians of their asthma conditions.[36]
Both first-hand and second-hand tobacco smoke can be a trigger for asthma attack.[41] It may worsen the condition of asthma as it is an irritant and induces bronchoconstriction.[42]
Psychological triggersedit
Studies have also indicated that psychological stress may be associated with a higher chance of asthma attack.[5] Patients with psychological stress are found to have a reduced awareness of controlling asthma and a less desirable physical health.[5][43]
Symptomedit
One of the clinical asthmatic symptoms is shortness of breath due to narrowing of the respiratory tract, caused by mucus plug formation and bronchoconstriction as smooth muscles contract.[44] Another typical symptom is wheezing. During expiration, turbulent airflow crushes the narrowed respiratory tract, leading to a wheezing sound.[45] Moreover, the increased mucus secretion may not be limited to the respiratory tract, and other symptoms such as watery eyes and rhinitis are also common.[45] Furthermore, increased vasodilation and vascular permeability may result in angioedema, the swelling of the skin, and hives.[46] In severe complications, as ventilation is impaired, acute respiratory failure may occur due to the inadequate amount of oxygen in the circulatory system.[47] Another life-threatening condition is pneumothorax, the collapse of the lungs due to hyperinflation.[48]
Avoidanceedit
Understanding the specific asthma triggers for a patient and avoiding them can be a simple way for preventing an asthma attack.[41] Regularly washing beddings, quitting smoking, doing pest controls, keeping a sensitized living environment, removing stagnant water, avoiding products with potential irritants, etc., can be effective in avoiding an asthma attack.[41]
Education about asthma triggers should be done by physicians to help patients understand what activities or materials should be avoided. Reduction of exposure to asthma triggers should be done by asthmatic patient as well.[4] Parents of asthmatic children should also be cautious of common asthma triggers in order to reduce risks of an asthma attack.[22]
Treatmentedit
Quick-relief medicineedit
Quick-relief medicine are used for treating an acute asthma attack. The first line of medicine for treating this situation is short-term beta-2-adrenoreceptor agonists, which are drugs that can stimulate the beta-2 adrenergic receptors. They are bronchodilators and can effectively relieve the symptoms by clearing the airway. Examples include albuterol and levalbuterol.[7] Commonly they are used with a portable inhaler which allows the patient to administer the medicine at once during an attack.
Another type of treatment for acute asthma attack is immunosuppressive drugs like corticosteroids, which can also alleviate an asthmatic response.[49] Examples include prednisone and methyl prednisone which are usually administered orally or intravenously for treating an acute situation.[7] However, note that long term use of corticosteroids may lead to severe side effects.
Long-term controledit
Continuous and long-term use of certain medicines can help reduce the risk of an asthma attack and keep the disease under control.
Long term use of certain types of corticosteroids, such as fluticasone propionate may be administered through the pulmonary route to reduce the risk of an asthma attack.[50]
Moreover, another option is the use of cromolyn sodium, which can prevent an asthma attack by halting Ca2+ influx, thus preventing mast cell degranulation and subsequent asthmatic complications [53]
Other than drugs, an alternative treatment method is de-sensitization, which involves exposure to a well-controlled, small and increasing amounts of specific allergen over a long duration of time.[54] The rationale is to trigger antigen competition by the development of allergen-specific IgG antibodies, which can reduce to risk of an allergic response.[54]
^"Trigger", McGraw-Hill Concise Dictionary of Modern Medicine, retrieved 2022-03-29
^British Thoracic Society; Scottish Intercollegiate Guidelines Network (2014). "British guideline on the management of asthma". Thorax. 69 (Suppl 1): 1–192. ISSN 1468-3296. PMID 25323740.
^ abcMorris. M, MD, FACP, FCCP (2021-05-03). "Asthma: Practice Essentials, Background, Anatomy". Medscape.{{cite journal}}: CS1 maint: multiple names: authors list (link)
^ abcVernon, Margaret K.; Wiklund, Ingela; Bell, Jill A.; Dale, Peter; Chapman, Kenneth R. (2012-11-19). "What Do We Know about Asthma Triggers? A Review of the Literature". Journal of Asthma. 49 (10): 991–998. doi:10.3109/02770903.2012.738268. ISSN 0277-0903. PMID 23574397. S2CID 38294258.
^ abcRitz, Thomas; Steptoe, Andrew; Bobb, Carol; Harris, Alexander H. S.; Edwards, Martin (2006). "The Asthma Trigger Inventory: Validation of a Questionnaire for Perceived Triggers of Asthma". Psychosomatic Medicine. 68 (6): 956–965. doi:10.1097/01.psy.0000248898.59557.74. ISSN 0033-3174. PMID 17132841. S2CID 31788889.
^Viswam, Darsana; Mansur, Adel H. (2020). "Mode of onset and triggers of severe asthma". Annals of Allergy, Asthma & Immunology. 128 (4): 466–467. doi:10.1016/j.anai.2022.01.006. ISSN 1081-1206. PMID 35031415. S2CID 245916683.
^ abcdeBissell, Karen; Ellwood, Philippa; Ellwood, Eamon; Chiang, Chen-Yuan; Marks, Guy; El Sony, Asma; Asher, Innes; Billo, Nils; Perrin, Christophe (2019-02-19). "Essential Medicines at the National Level: The Global Asthma Network's Essential Asthma Medicines Survey 2014". International Journal of Environmental Research and Public Health. 16 (4): 605. doi:10.3390/ijerph16040605. ISSN 1660-4601. PMC6406388. PMID 30791442.
^Humeniuk, Piotr; Dubiela, Pawel; Hoffmann-Sommergruber, Karin (2017-07-11). "Dendritic Cells and Their Role in Allergy: Uptake, Proteolytic Processing and Presentation of Allergens". International Journal of Molecular Sciences. 18 (7): 1491. doi:10.3390/ijms18071491. ISSN 1422-0067. PMC5535981. PMID 28696399.
^ abSaunders, Sean P.; Ma, Erica G. M.; Aranda, Carlos J.; Curotto de Lafaille, Maria A. (2019-04-26). "Non-classical B Cell Memory of Allergic IgE Responses". Frontiers in Immunology. 10: 715. doi:10.3389/fimmu.2019.00715. ISSN 1664-3224. PMC6498404. PMID 31105687.
^ abHolgate, Stephen T (2013). "Mechanisms of Asthma and Implications for Its Prevention and Treatment: A Personal Journey". Allergy, Asthma & Immunology Research. 5 (6): 343–347. doi:10.4168/aair.2013.5.6.343. ISSN 2092-7355. PMC3810539. PMID 24179679.
^Bradding, P; Feather, I H; Howarth, P H; Mueller, R; Roberts, J A; Britten, K; Bews, J P; Hunt, T C; Okayama, Y; Heusser, C H (1992-11-01). "Interleukin 4 is localized to and released by human mast cells". Journal of Experimental Medicine. 176 (5): 1381–1386. doi:10.1084/jem.176.5.1381. ISSN 0022-1007. PMC2119427. PMID 1402683. S2CID 7033172.
^Beasley, Richard; Roche, William R.; Roberts, J. Alan; Holgate, Stephen T. (1989). "Cellular Events in the Bronchi in Mild Asthma and after Bronchial Provocation". American Review of Respiratory Disease. 139 (3): 806–817. doi:10.1164/ajrccm/139.3.806. ISSN 0003-0805. PMID 2923380.
^Gilfillan, Alasdair M.; Rivera, Juan (2009). "The tyrosine kinase network regulating mast cell activation". Immunological Reviews. 228 (1): 149–169. doi:10.1111/j.1600-065x.2008.00742.x. ISSN 0105-2896. PMC2669301. PMID 19290926.
^Klein, Ofir; Sagi-Eisenberg, Ronit (2019-03-18). "Anaphylactic Degranulation of Mast Cells: Focus on Compound Exocytosis". Journal of Immunology Research. 2019: 1–12. doi:10.1155/2019/9542656. ISSN 2314-8861. PMC6442490. PMID 31011586.
^Goetzl, E J; Austen, K F (1976-12-01). "Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis". Journal of Experimental Medicine. 144 (6): 1424–1437. doi:10.1084/jem.144.6.1424. ISSN 0022-1007. PMC2190483. PMID 1003098.
^Ong, W.-Y.; Farooqui, T.; Farooqui, A.A. (2010-09-01). "Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions". Current Medicinal Chemistry. 17 (25): 2746–2763. doi:10.2174/092986710791859289. ISSN 0929-8673. PMID 20586719.
^Funk, Colin D. (2001-11-30). "Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology". Science. 294 (5548): 1871–1875. Bibcode:2001Sci...294.1871F. doi:10.1126/science.294.5548.1871. ISSN 0036-8075. PMID 11729303.
^Cargnello, Marie; Roux, Philippe P. (2011). "Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases". Microbiology and Molecular Biology Reviews. 75 (1): 50–83. doi:10.1128/mmbr.00031-10. ISSN 1092-2172. PMC3063353. PMID 21372320.
^ abZhang, Jun-Ming; An, Jianxiong (2007). "Cytokines, Inflammation, and Pain". International Anesthesiology Clinics. 45 (2): 27–37. doi:10.1097/aia.0b013e318034194e. ISSN 0020-5907. PMC2785020. PMID 17426506.
^D'Amato, M; Cecchi, L; Annesi-Maesano, I; D'Amato, G (2018-04-16). "News on Climate Change, Air Pollution, and Allergic Triggers of Asthma". Journal of Investigational Allergology and Clinical Immunology. 28 (2): 91–97. doi:10.18176/jiaci.0228. ISSN 1018-9068. PMID 29345235.
^ abMorgan, Wayne J.; Crain, Ellen F.; Gruchalla, Rebecca S.; O'Connor, George T.; Kattan, Meyer; Evans, Richard; Stout, James; Malindzak, George; Smartt, Ernestine; Plaut, Marshall; Walter, Michelle (2004-09-09). "Results of a Home-Based Environmental Intervention among Urban Children with Asthma". New England Journal of Medicine. 351 (11): 1068–1080. doi:10.1056/nejmoa032097. ISSN 0028-4793. PMID 15356304.
^Eder, Waltraud; Ege, Markus J.; von Mutius, Erika (2006-11-23). "The Asthma Epidemic". New England Journal of Medicine. 355 (21): 2226–2235. doi:10.1056/NEJMra054308. ISSN 0028-4793. PMID 17124020.
^Busse, William W; Lemanske, Robert F; Gern, James E (2010). "Role of viral respiratory infections in asthma and asthma exacerbations". The Lancet. 376 (9743): 826–834. doi:10.1016/S0140-6736(10)61380-3. PMC2972660. PMID 20816549.
^Peden, David B. (2005). "The epidemiology and genetics of asthma risk associated with air pollution". Journal of Allergy and Clinical Immunology. 115 (2): 213–219. doi:10.1016/j.jaci.2004.12.003. ISSN 0091-6749. PMID 15696070.
^Braun-Fahrländer, Charlotte; Riedler, Josef; Herz, Udo; Eder, Waltraud; Waser, Marco; Grize, Leticia; Maisch, Soyoun; Carr, David; Gerlach, Florian; Bufe, Albrecht; Lauener, Roger P. (2002-09-19). "Environmental Exposure to Endotoxin and Its Relation to Asthma in School-Age Children". New England Journal of Medicine. 347 (12): 869–877. doi:10.1056/nejmoa020057. ISSN 0028-4793. PMID 12239255.
^Liu, Ting; Wang, Fa-Ping; Wang, Geng; Mao, Hui (2017). "Role of Neutrophil Extracellular Traps in Asthma and Chronic Obstructive Pulmonary Disease". Chinese Medical Journal. 130 (6): 730–736. doi:10.4103/0366-6999.201608. ISSN 0366-6999. PMC5358425. PMID 28303858.
^ abMcGwin, Gerald; Lienert, Jeffrey; Kennedy, John I. (2010). "Formaldehyde Exposure and Asthma in Children: A Systematic Review". Environmental Health Perspectives. 118 (3): 313–317. doi:10.1289/ehp.0901143. ISSN 0091-6765. PMC2854756. PMID 20064771.
^Crapo, R. O.; Casaburi, R.; Coates, A. L.; Enright, P. L.; Hankinson, J. L.; Irvin, C. G.; MacIntyre, N. R.; McKay, R. T.; Wanger, J. S.; Anderson, S. D.; Cockcroft, D. W.; Fish, J. E.; Sterk, P. J. (2000). "Guidelines for Methacholine and Exercise Challenge Testing—1999". American Journal of Respiratory and Critical Care Medicine. 161 (1): 309–329. doi:10.1164/ajrccm.161.1.ats11-99. ISSN 1073-449X. PMID 10619836.
^Raddeley, R (1988). "Surgical management of morbid obesity. W. O. Griffin Jr. 150 × 230 mm. Pp. 284. Illustrated. 1987. New York: Marcel Dekker Inc. $95.50". British Journal of Surgery. 75 (5): 503. doi:10.1002/bjs.1800750554. ISSN 0007-1323.
^Anderson, Sandra D.; Daviskas, Evangelia (2000). "The mechanism of exercise-induced asthma is …". Journal of Allergy and Clinical Immunology. 106 (3): 453–459. doi:10.1067/mai.2000.109822. ISSN 0091-6749. PMID 10984363.
^McFADDEN, E. R.; NELSON, JO ANN; SKOWRONSKI, M. E.; LENNER, K. A. (1999). "Thermally Induced Asthma and Airway Drying". American Journal of Respiratory and Critical Care Medicine. 160 (1): 221–226. doi:10.1164/ajrccm.160.1.9810055. ISSN 1073-449X. PMID 10390404.
^ abSzczeklik, Andrew; Stevenson, Donald D. (2003). "Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management". Journal of Allergy and Clinical Immunology. 111 (5): 913–921. doi:10.1067/mai.2003.1487. PMID 12743549.
^Morales, Daniel R.; Lipworth, Brian J.; Donnan, Peter T.; Jackson, Cathy; Guthrie, Bruce (2017). "Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study". BMC Medicine. 15 (1): 18. doi:10.1186/s12916-017-0781-0. ISSN 1741-7015. PMC5270217. PMID 28126029.
^"Medicines Can Trigger Asthma". Asthma and allergy foundation of america. 2018. Retrieved 2022-03-29.
^Tarlo, Susan M.; Lemiere, Catherine (2014-02-13). "Occupational Asthma". New England Journal of Medicine. 370 (7): 640–649. doi:10.1056/nejmra1301758. ISSN 0028-4793. PMID 24521110.
^"Handling fish can cause occupational asthma". Food and Chemical Toxicology. 35 (9): 930. 1997. doi:10.1016/s0278-6915(97)90051-x. ISSN 0278-6915.
^Baur, Xaver; Bakehe, Prudence (2014). "Allergens causing occupational asthma: an evidence-based evaluation of the literature". International Archives of Occupational and Environmental Health. 87 (4): 339–363. doi:10.1007/s00420-013-0866-9. ISSN 0340-0131. PMID 23595938. S2CID 38640302.
^Frontiers Production, Office (2022-03-23). "Erratum: Mechanisms of Particles in Sensitization, Effector Function and Therapy of Allergic Disease". Frontiers in Immunology. 13: 891445. doi:10.3389/fimmu.2022.891445. ISSN 1664-3224. PMC8985158. PMID 35401505.
^Bernstein, Jonathan A; Moellman, Joseph (2012-11-06). "Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema". International Journal of Emergency Medicine. 5 (1): 39. doi:10.1186/1865-1380-5-39. ISSN 1865-1380. PMC3518251. PMID 23131076. S2CID 9039857.
^Smyth, Melinda (2005). "Acute Respiratory Failure: Part 2. Failure of Ventilation". American Journal of Nursing. 105 (6): 72AA–72DD. doi:10.1097/00000446-200506000-00040. ISSN 0002-936X.
^E, Yiannakopoulou (2018-12-21). "Pneumothorax, pneumomediastinum, subcutaneous emphysema: serious complications of asthma". Archives of Asthma, Allergy and Immunology. 2 (1): 016–017. doi:10.29328/journal.aaai.1001014. ISSN 2639-3182. S2CID 80725017.
^Djukanović, Ratko; Wilson, John W.; Britten, Karen M.; Wilson, Susan J.; Walls, Andrew F.; Roche, William R.; Howarth, Peter H.; Holgate, Stephen T. (1992). "Effect of an Inhaled Corticosteroid on Airway Inflammation and Symptoms in Asthma". American Review of Respiratory Disease. 145 (3): 669–674. doi:10.1164/ajrccm/145.3.669. ISSN 0003-0805. PMID 1546849.
^Harrison, TW; Oborne, J; Newton, S; Tattersfield, AE (2004). "Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial". The Lancet. 363 (9405): 271–275. doi:10.1016/s0140-6736(03)15384-6. ISSN 0140-6736. PMID 14751699. S2CID 28581643.
^ abKrishna, M T; Huissoon, A P (2010-12-22). "Clinical immunology review series: an approach to desensitization". Clinical and Experimental Immunology. 163 (2): 131–146. doi:10.1111/j.1365-2249.2010.04296.x. ISSN 0009-9104. PMC3043304. PMID 21175592.
^Salpeter, Shelley R.; Wall, Andrew J.; Buckley, Nicholas S. (2010). "Long-acting Beta-Agonists with and without Inhaled Corticosteroids and Catastrophic Asthma Events". The American Journal of Medicine. 123 (4): 322–328.e2. doi:10.1016/j.amjmed.2009.07.035. PMID 20176343.
^Chowdhury, Badrul A.; Dal Pan, Gerald (2010). "The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma". New England Journal of Medicine. 362 (13): 1169–1171. doi:10.1056/NEJMp1002074. ISSN 0028-4793. PMID 20181964.